Onderneming Eledon Pharmaceuticals, Inc.
Aandelen
ELDN
US28617K1016
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,54 USD | +6,72% |
|
-2,68% | +41,11% |
Vakgebied
Aantal werknemers: 20
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 51 | 01-05-20 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 15-03-21 |
Steven Perrin
PSD | President | 59 | 14-09-20 |
Eliezer Katz
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-23 |
John Herberger
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-22 |
Bryan Smith
CMP | Compliance Officer | 45 | 19-04-21 |
David Hovland
LAW | General Counsel | - | 19-04-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 01-05-17 |
Walter Ogier
BRD | Director/Board Member | 67 | 14-09-20 |
John McBride
BRD | Director/Board Member | 72 | 01-05-17 |
Steven Perrin
PSD | President | 59 | 14-09-20 |
Chief Executive Officer | 51 | 01-05-20 | |
James Robinson
BRD | Director/Board Member | 54 | 01-10-23 |
June Lee
BRD | Director/Board Member | 58 | 09-12-20 |
Jan Hillson
BRD | Director/Board Member | 71 | 02-07-21 |
Allan Kirk
BRD | Director/Board Member | 62 | 02-10-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 110 086 | 0 | 0 | 96,49 % |
Aandeel B | 1 | 38 506 614 | 37 155 255 ( 96,49 %) | 0 | |
Aandeel C | 0 | 4 422 | 0 | 0 |
Bedrijfsgegevens
![Adres Eledon Pharmaceuticals, Inc.(ELDN)](https://cdn.zonebourse.com/static/address/117251081.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,11% | 97,81 mln. | |
+16,49% | 122 mld. | |
+21,73% | 115 mld. | |
+22,13% | 26,64 mld. | |
-21,81% | 19,91 mld. | |
-16,77% | 16,32 mld. | |
-44,74% | 15,52 mld. | |
-18,81% | 15,49 mld. | |
+62,72% | 14,83 mld. | |
+3,09% | 13,67 mld. |
- Beurs
- Aandelen
- Koers ELDN
- Onderneming Eledon Pharmaceuticals, Inc.